These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 38310873)

  • 1. Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective.
    Jung I; Koo DJ; Lee WY
    Diabetes Metab J; 2024 May; 48(3):327-339. PubMed ID: 38310873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty Liver, Insulin Resistance, and Obesity: Relationships With Increase in Coronary Artery Calcium Over Time.
    Sung KC; Ryu S; Lee JY; Lee SH; Cheong ES; Wild SH; Byrne CD
    Clin Cardiol; 2016 Jun; 39(6):321-8. PubMed ID: 26997000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver.
    Sung KC; Lee MY; Kim YH; Huh JH; Kim JY; Wild SH; Byrne CD
    Atherosclerosis; 2018 Aug; 275():50-57. PubMed ID: 29860108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter.
    Chon YE; Kim KJ; Jung KS; Kim SU; Park JY; Kim do Y; Ahn SH; Chon CY; Chung JB; Park KH; Bae JC; Han KH
    Yonsei Med J; 2016 Jul; 57(4):885-92. PubMed ID: 27189281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
    Portillo Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
    J Clin Endocrinol Metab; 2014 Oct; 100(5):. PubMed ID: 25303488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese.
    Sung KC; Seo DC; Lee SJ; Lee MY; Wild SH; Byrne CD
    Nutr Metab Cardiovasc Dis; 2019 May; 29(5):489-495. PubMed ID: 30940491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
    Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?
    Firneisz G
    World J Gastroenterol; 2014 Jul; 20(27):9072-89. PubMed ID: 25083080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes?
    Gutierrez-Buey G; Núñez-Córdoba JM; Llavero-Valero M; Gargallo J; Salvador J; Escalada J
    Eur J Intern Med; 2017 Jun; 41():74-78. PubMed ID: 28283346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
    Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
    World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of insulin resistance in the occurence of non-alcoholic fatty liver disease among first degree relatives of type 2 diabetes.
    Hazim A; Purnamasari D; Kalista KF; Lesmana CRA; Nugroho P
    Diabetes Metab Syndr; 2019; 13(2):1431-1435. PubMed ID: 31336502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-five-year trajectories of insulin resistance and pancreatic β-cell response and diabetes risk in nonalcoholic fatty liver disease.
    VanWagner LB; Ning H; Allen NB; Siddique J; Carson AP; Bancks MP; Lewis CE; Carr JJ; Speliotes E; Terrault NA; Rinella ME; Vos MB; Lloyd-Jones DM
    Liver Int; 2018 Nov; 38(11):2069-2081. PubMed ID: 29608255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in Insulin Sensitivity, Secretion, and the Metabolic Clearance Rate of Glucose in Newly Diagnosed Type 2 Diabetes Mellitus Patients: The Influences of Body Mass Index and Fatty Liver.
    Xie Y; Li S; Chen R; He R; Qian L; Zou J; Luo Y; Zhang Y; Ji M; Liu Y
    Metab Syndr Relat Disord; 2022 Oct; 20(8):451-458. PubMed ID: 36260098
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.
    Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ
    J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
    Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
    Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
    Yi M; Chen RP; Yang R; Chen H
    Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus.
    Lee H; Kim G; Choi YJ; Huh BW; Lee BW; Kang ES; Cha BS; Lee EJ; Lee YH; Huh KB
    Diabetes Metab J; 2020 Apr; 44(2):267-276. PubMed ID: 30877708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk factors for type 2 diabetes mellitus with Prader-Willi syndrome: a single center experience.
    Yang A; Kim J; Cho SY; Jin DK
    Orphanet J Rare Dis; 2017 Aug; 12(1):146. PubMed ID: 28854950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
    Moh Moh MA; Jung CH; Lee B; Choi D; Kim BY; Kim CH; Kang SK; Mok JO
    Diab Vasc Dis Res; 2019 Mar; 16(2):186-195. PubMed ID: 30428692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic Fatty Liver Disease and Diabetes: An Epidemiological Perspective.
    Rhee EJ
    Endocrinol Metab (Seoul); 2019 Sep; 34(3):226-233. PubMed ID: 31565874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.